Harmonizing lipidomics: NIST interlaboratory comparison exercise for lipidomics using SRM 1950–Metabolites in Frozen Human Plasma [S] JA Bowden, A Heckert, CZ Ulmer, CM Jones, JP Koelmel, L Abdullah, ... Journal of lipid research 58 (12), 2275-2288, 2017 | 356 | 2017 |
Quantitative analysis of endogenous compounds R Thakare, YS Chhonker, N Gautam, JA Alamoudi, Y Alnouti Journal of pharmaceutical and biomedical analysis 128, 426-437, 2016 | 205 | 2016 |
Species differences in bile acids I. Plasma and urine bile acid composition R Thakare, JA Alamoudi, N Gautam, AD Rodrigues, Y Alnouti Journal of applied toxicology 38 (10), 1323-1335, 2018 | 108 | 2018 |
Urinary bile acids as biomarkers for liver diseases I. Stability of the baseline profile in healthy subjects SPR Bathena, R Thakare, N Gautam, S Mukherjee, M Olivera, J Meza, ... Toxicological sciences 143 (2), 296-307, 2015 | 59 | 2015 |
Species differences in bile acids II. Bile acid metabolism R Thakare, JA Alamoudi, N Gautam, AD Rodrigues, Y Alnouti Journal of applied toxicology 38 (10), 1336-1352, 2018 | 51 | 2018 |
Urinary bile acids as biomarkers for liver diseases II. Signature profiles in patients SPR Bathena, R Thakare, N Gautam, S Mukherjee, M Olivera, J Meza, ... Toxicological sciences 143 (2), 308-318, 2015 | 43 | 2015 |
Leveraging of rifampicin-dosed cynomolgus monkeys to identify bile acid 3-O-sulfate conjugates as potential novel biomarkers for organic anion-transporting polypeptides R Thakare, H Gao, RE Kosa, YA Bi, MVS Varma, MA Cerny, R Sharma, ... Drug Metabolism and Disposition 45 (7), 721-733, 2017 | 42 | 2017 |
Harmonizing lipidomics: NIST interlaboratory comparison exercise for lipidomics using standard reference material 1950 metabolites in frozen human plasma JA Bowden, A Heckert, CZ Ulmer, CM Jones, JP Koelmel, L Abdullah, ... J. Lipid Res 58 (12), 2275-2288, 2017 | 40 | 2017 |
Peripherally cross-linking the shell of core-shell polymer micelles decreases premature release of physically loaded combretastatin A4 in whole blood and increases its mean … RR Wakaskar, SPR Bathena, SB Tallapaka, VV Ambardekar, N Gautam, ... Pharmaceutical research 32, 1028-1044, 2015 | 40 | 2015 |
Pharmaceutical stability testing to support global markets K Huynh-Ba Springer Science & Business Media, 2009 | 31 | 2009 |
Simultaneous LC–MS/MS analysis of eicosanoids and related metabolites in human serum, sputum and BALF R Thakare, YS Chhonker, N Gautam, A Nelson, R Casaburi, G Criner, ... Biomedical Chromatography 32 (3), e4102, 2018 | 29 | 2018 |
Characterization of CDK (5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy CM Robb, S Kour, JI Contreras, E Agarwal, CJ Barger, S Rana, ... Oncotarget 9 (4), 5216, 2018 | 29 | 2018 |
A2B adenosine receptor antagonists: design, synthesis and biological evaluation of novel xanthine derivatives S Basu, DA Barawkar, V Ramdas, Y Waman, M Patel, A Panmand, ... European journal of medicinal chemistry 127, 986-996, 2017 | 27 | 2017 |
Design, Synthesis of Novel, Potent, Selective, Orally Bioavailable Adenosine A2A Receptor Antagonists and Their Biological Evaluation S Basu, DA Barawkar, S Thorat, YD Shejul, M Patel, M Naykodi, V Jain, ... Journal of Medicinal Chemistry 60 (2), 681-694, 2017 | 27 | 2017 |
Pharmacokinetics, biodistribution, and toxicity of folic acid-coated antiretroviral nanoformulations N Gautam, P Puligujja, S Balkundi, R Thakare, XM Liu, HS Fox, ... Antimicrobial agents and chemotherapy 58 (12), 7510-7519, 2014 | 27 | 2014 |
Increased glycine-amidated hyocholic acid correlates to improved early weight loss after sleeve gastrectomy TL Kindel, C Krause, MC Helm, CL McBride, D Oleynikov, R Thakare, ... Surgical endoscopy 32, 805-812, 2018 | 18 | 2018 |
Irreversible binding of an anticancer compound (BI-94) to plasma proteins N Gautam, R Thakare, S Rana, A Natarajan, Y Alnouti Xenobiotica 45 (10), 858-873, 2015 | 10 | 2015 |
Circulating bile acid levels direct sex-differences in liver cancer development ME Patton, S Kelekar, LJ Taylor, R Thakare, S Lee, Y Alnouti, ... BioRxiv, 2020 | 5* | 2020 |
Design and synthesis of novel, potent and selective hypoxanthine analogs as adenosine A1 receptor antagonists and their biological evaluation S Koul, V Ramdas, DA Barawkar, YB Waman, N Prasad, SK Madadi, ... Bioorganic & Medicinal Chemistry 25 (6), 1963-1975, 2017 | 5 | 2017 |
Correction: Characterization of CDK (5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy CM Robb, S Kour, JI Contreras, E Agarwal, CJ Barger, S Rana, ... Oncotarget 11 (25), 2462, 2020 | 3 | 2020 |